Cavanaugh Sarah
Insider CIK 1709113 · CLDX SVP of Corp Affairs & Admin.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 95,000 | — | $0 | 95,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 78,000 | — | $0 | 78,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 78,000 | — | $0 | 78,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2024-05-30 | 2024-06-03 | 10,103 | — | $0 | 0 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2024-05-30 | 2024-06-03 | 10,750 | — | $0 | 0 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2024-05-30 | 2024-06-03 | 10,750 | $2.78 | $29.9K | 12,610 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2024-05-30 | 2024-06-03 | 10,103 | $9.02 | $91.1K | 22,713 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2024-05-30 | 2024-06-03 | 20,853 | $33.73 | $703.4K | 1,860 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2022-08-18 | 2022-08-19 | 1,355 | — | $0 | 10,103 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2022-08-18 | 2022-08-19 | 1,355 | $36.38 | $49.3K | 1,284 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2022-08-18 | 2022-08-19 | 1,355 | $9.02 | $12.2K | 2,639 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2022-08-17 | 2022-08-19 | 31,312 | — | $0 | 10,750 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2022-08-17 | 2022-08-19 | 31,312 | $2.78 | $87.0K | 32,596 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-19 | 31,312 | $36.73 | $1.15M | 1,284 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 73,000 | — | $0 | 73,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2021-12-08 | 2021-12-10 | 5,466 | — | $0 | 78,534 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2021-12-08 | 2021-12-10 | 1,857 | — | $0 | 11,458 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2021-12-08 | 2021-12-10 | 5,466 | $10.38 | $56.7K | 7,731 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2021-12-08 | 2021-12-10 | 7,323 | $40.00 | $292.9K | 408 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2021-12-08 | 2021-12-10 | 1,857 | $9.02 | $16.8K | 2,265 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 5,018 | — | $0 | 13,315 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 938 | — | $0 | 42,062 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 938 | $2.78 | $2.6K | 7,731 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 4,302 | $44.11 | $189.8K | 3,429 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 2,120 | $41.62 | $88.2K | 408 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 901 | $43.06 | $38.8K | 2,528 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 5,018 | $9.02 | $45.3K | 6,793 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 56,000 | — | $0 | 56,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 84,000 | — | $0 | 84,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | P Buy | 2020-06-10 | 2020-06-11 | 1,050 | $4.83 | $5.1K | 1,367 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-20 | 43,000 | — | $0 | 43,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 275,000 | — | $0 | 275,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-16 | 65,000 | — | $0 | 65,000 | SEC↗ |